Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Microcap & Penny Stocks : EXTI - only public co. developing liver device -- Ignore unavailable to you. Want to Upgrade?

To: PitBull who wrote (204)	2/19/1998 10:38:00 PM
From: MaxLeverage	Read Replies (1) \| Respond to of 1063

American Society for Artificial Internal Organs 44th Annual Conference The New York Hilton, New York, New York April 23-25, 1998 Thursday, April 23, 1998 1:00 - 3:00 Panel: ARTIFICIAL LIVER SUPPORT IN 1998ÿ Chair: Amy L. Friedman, MD, Asst. Prof of Surgery, Yale Univ. Sch of Med.ÿ Current Status of Artificial Liver Support Technology and Animal Models of Liver Failureÿ Scott L. Nyberg, MD, PhD, Assistant Professor of Surgery, Mayo Clinicÿ Which Patients are Candidates in 1998?ÿ Victor J. Navarro, MD, Assistant Professor of Medicine, Yale Univ School of Medicineÿ Active Clinical Trials in 1998ÿ Achilles A. Demetriou, MD, PhD, Chairman, Department of Surgery, Cedars-Sinai Medical Centerÿ Panel Discussionÿ Amy L. Friedman, MD, Asst. Professor of Surgery, Yale Univ. Sch of Med.ÿhttp://asaio.com/pre4-23.htm Is anyone familiar with this conference and it's potential for Exten shareholders? Keep in mind that " Dr. Amy Friedman, Chief Liver Transplantation Services, Division of Organ Transplantation at Yale University is a member of Exten's ScientificAdvisory Board.." exten.com